Articles from Adverse Event Reporting News (July 30, 2007)

Title	Author	Type	Words
Baxter recalls infusion pumps.		Brief article	146
Bayer Healthcare recalls glucose monitoring system.		Brief article	122
Boston Scientific will settle all pending federal suits.			331
EMEA recommends withdrawal of products containing veralipride.		Brief article	194
EMEA satisfied with achievements, progress in risk management.	Mashaw, Rebecca		396
EMEA toughens warning on Sanofi anti-obesity drug.		Brief article	259
FDA bonuses to be reviewed; critics say funds not used well.			405
FDA to convene panel to discuss anemia drug.			322
FDA warns Medtronic over its drug-infusion pumps.		Brief article	250
Fewer stents implanted in June, signaling impact of new studies.		Brief article	273
Inappropriate prescribing for older patients a growing problem.		Brief article	237
Medical illiteracy deadly for seniors.			440
New study confirms link between breast cancer and hormone therapy.			636
Nigeria files new Pfizer claims.		Brief article	281
Panel recommends FDA approve osteoporosis drug to cut breast cancer risk.			799
Patient death leads FDA to suspend gene therapy study.			399
Recall of AIDS drug hits world's poor.			1151
Restricted use of Zelnorm allowed for qualifying patients.			351
Safety labeling changes approved by CDER--April 2007.			3951
Senators say FDA pulled scientist off Avandia review.		Brief article	203
Suicide findings question link to antidepressants.			676
Thoratec recalls VADs.		Brief article	258
Vioxx's risks may begin earlier than thought.			511